Insulin efsitora alfa for treating type 2 diabetes in people on daily insulin injections [ID6499]

  • Awaiting development
  • GID-TA11644
  • Expected publication date: TBC

Suggested remit: To appraise the clinical and cost effectiveness of Efsitora alfa within its marketing authorisation for treating type 2 diabetes in people on daily insulin injections